Merck Net Worth

Merck Net Worth Analysis

Merck Target Price Consensus

Merck Target Price Projection

Merck's current and average target prices are 83.01 and 127.73, respectively. The current price of Merck is the price at which Merck Company is currently trading. On the other hand, Merck's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Merck Company and the information provided on this page.

Know Merck's Top Institutional Investors

Note, although Merck's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Merck's market capitalization trends

The company currently falls under 'Mega-Cap' category with a total capitalization of 209.99 B.

Project Merck's profitablity

The company has Net Profit Margin of 0.27 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.33 %, which entails that for every 100 dollars of revenue, it generated $0.33 of operating income.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Merck's management efficiency

Merck Company has Return on Asset of 0.1053 % which means that on every $100 spent on assets, it made $0.1053 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.4169 %, implying that it generated $0.4169 on every 100 dollars invested. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to 0.01. The value of Return On Capital Employed is expected to slide to 0.04. At this time, Merck's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 128.8 B this year, although the value of Change To Liabilities will most likely fall to (476.3 M).

Merck Corporate Filings

Merck time-series forecasting models is one of many Merck's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Merck's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Merck Earnings Estimation Breakdown

The calculation of Merck's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Merck is estimated to be 2.1278 with the future projection ranging from a low of 1.96 to a high of 2.25. Please be aware that this consensus of annual earnings estimates for Merck Company is based on EPS before non-recurring items and includes expenses related to employee stock options.

Merck Earnings Projection Consensus

Merck Earnings History

Earnings estimate consensus by Merck Company analysts from Wall Street is used by the market to judge Merck's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Merck's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods. Price Earnings Ratio is expected to rise to 735.88 this year, although the value of Retained Earnings will most likely fall to about 32.6 B. Net Income Applicable To Common Shares is expected to rise to about 17.5 B this year, although the value of Common Stock Shares Outstanding will most likely fall to about 2.7 B.

Hype Prediction Low Estimated High 81.14 82.83 84.52 Details

Intrinsic Valuation Low Real High 74.71 97.48 99.17 Details

Naive Forecast Low Next High 78.43 80.12 81.81 Details

28 Analysts Consensus Low Target High 116.23 127.73 141.78 Details

Note that many institutional investors and large investment bankers can move markets due to the volume of Merck assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Merck. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Merck's stock price in the short term.

Merck Earnings per Share Projection vs Actual

Actual Earning per Share of Merck refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Merck Company predict the company's earnings will be in the future. The higher the earnings per share of Merck, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Merck Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Merck, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Merck should always be considered in relation to other companies to make a more educated investment decision.

Merck Quarterly Analyst Estimates and Surprise Metrics

Merck Corporate Directors

When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:

How To Invest In Merck Details

Is Merck Stock a good investment? Details

What is Merck's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details